For example, CD4+ and CD8+ T cells in CSF during MS relapse had enriched CXCR3 expression, but reduced CCR3 and CCR4 expression, compared with CD4+ and CD8+ T cells in the blood [83]. Here, CD8A is linked to myeloid sarcoma.